Abstract
Fungi can be found throughout the world. They may live as saprophytes, parasites or symbionts of animals and plants in indoor as well as outdoor environment. For decades, fungi belonging to the ascomycota as well as to the basidiomycota have been known to cause a broad panel of human disorders. In contrast to pollen, fungal spores and/or mycelial cells may not only cause type I allergy, the most prevalent disease caused by molds, but also a large number of other illnesses, including allergic bronchopulmonary mycoses, allergic sinusitis, hypersensitivity pneumonitis and atopic dermatitis; and, again in contrast to pollen-derived allergies, fungal allergies are frequently linked with allergic asthma. Sensitization to molds has been reported in up to 80% of asthmatic patients. Although research on fungal allergies dates back to the 19th century, major improvements in the diagnosis and therapy of mold allergy have been hampered by the fact that fungal extracts are highly variable in their protein composition due to strain variabilities, batch-to-batch variations, and by the fact that extracts may be prepared from spores and/or mycelial cells. Nonetheless, about 150 individual fungal allergens from approximately 80 mold genera have been identified in the last 20 years. First clinical studies with recombinant mold allergens have demonstrated their potency in clinical diagnosis. This review aims to give an overview of the biology of molds and diseases caused by molds in humans, as well as a detailed summary of the latest results on recombinant fungal allergens.
References
1.
De Hoog GS, Guarro J, Gene J, Figueras MJ: Atlas of Clinical Fungi, ed 2. Utrecht, Centraalbureau voor Schimmelcultures, 2000.
2.
Kauffman HF, Tomee JF, van der Werf TS, de Monchy JG, Koeter GK: Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med 1995;151:2109–2115, discussion 2116.
3.
Bush RK, Portnoy JM, Saxon A, Terr AI, Wood RA: The medical effects of mold exposure. J Allergy Clin Immunol 2006;117:326–333.
4.
Kauffman HF, Tomee JF, van de Riet MA, Timmerman AJ, Borger P: Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J Allergy Clin Immunol 2000;105:1185–1193.
5.
Fischer G, Schwalbe R, Moller M, Ostrowski R, Dott W: Species-specific production of microbial volatile organic compounds (MVOC) by airborne fungi from a compost facility. Chemosphere 1999;39:795–810.
6.
Ingold CT, Hudson HJ: The Biology of Fungi, ed 6, revised. London, Chapman & Hall, 1993.
7.
Lacey L: The aerobiology of conidial fungi; in Cole GT, Kendrick B (eds): Biology of Conidial Fungi. New York, Academic Press, 1981, pp 123–128.
8.
D’Amato G, Spieksma FT: Aerobiologic and clinical aspects of mould allergy in Europe. Allergy 1995;50:870–877.
9.
Burge HA: Airborne allergenic fungi classification, nomenclature, and distribution. Immunol Allergy Clin North Am 1989;9:307–319.
10.
Burge HA: Fungus allergens. Clin Rev Allergy 1985;3:319–329.
11.
Dharmage S, Bailey M, Raven J, Mitakakis T, Thien F, Forbes A, Guest D, Abramson M, Walters EH: Prevalence and residential determinants of fungi within homes in Melbourne, Australia. Clin Exp Allergy 1999;29:1481–1489.
12.
Nevalainen A, Rautiala S, Hyvarinen A, Reponen T, Husman T, Kalliokoski P: Exposure to fungal spores in mouldy houses: effect of remedial work; in Agashe SN (ed): Recent Trends in Aerobiology, Allergy and Immunology. New Delhi, Oxford & IBH, 1994, pp 99–107.
13.
Gravesen S, Nielsen PA, Iversen R, Nielsen KF: Microfungal contamination of damp buildings – examples of risk constructions and risk materials. Environ Health Perspect 1999;107(suppl 3):505–508.
14.
Kurup VP: Fungal Allergy; in Arora N (ed): Handbook of Fungal Biotechnology. New York, Dekker, 2003, pp 515–525.
15.
Brummund W, Kurup VP, Harris GJ, Duncavage JA, Arkins JA: Allergic sino-orbital mycosis. A clinical and immunologic study. JAMA 1986;256:3249–3253.
16.
O’Brien IM, Bull J, Creamer B, Sepulveda R, Harries M, Burge PS, Pepys J: Asthma and extrinsic allergic alveolitis due to Merulius lacrymans. Clin Allergy 1978;8:535–542.
17.
Sastre J, Ibanez MD, Lopez M, Lehrer SB: Respiratory and immunological reactions among Shiitake (Lentinus edodes) mushroom workers. Clin Exp Allergy 1990;20:13–19.
18.
Bhatnagar D, Yu J, Ehrlich KC: Toxins of filamentous fungi. Chem Immunol 2002;81:167–206.
19.
Samson RA: Mycotoxins: a mycologist’s perspective. J Med Vet Mycol 1992;30(suppl 1): 9–18.
20.
Tariq SM, Matthews SM, Stevens M, Hakim EA: Sensitization to Alternaria and Cladosporium by the age of 4 years. Clin Exp Allergy 1996;26:794–798.
21.
Salvaggio J, Aukrust L: Postgraduate course presentations. Mold-induced asthma. J Allergy Clin Immunol 1981;68:327–346.
22.
Corey JP, Kaiseruddin S, Gungor A: Prevalence of mold-specific immunoglobulins in a Midwestern allergy practice. Otolaryngol Head Neck Surg 1997;117:516–520.
23.
Lopez M, Salvaggio JE: Mold-sensitive asthma. Clin Rev Allergy 1985;3:183–196.
24.
Hsieh KH, Shen JJ: Prevalence of childhood asthma in Taipei, Taiwan, and other Asian Pacific countries. J Asthma 1988;25:73–82.
25.
Horst M, Hejjaoui A, Horst V, Michel FB, Bousquet J: Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 1990;85:460–472.
26.
Zureik M, Neukirch C, Leynaert B, Liard R, Bousquet J, Neukirch F: Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ 2002;325:411–414.
27.
Denning DW, O’Driscoll BR, Hogaboam CM, Bowyer P, Niven RM: The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006;27:615–626.
28.
Targonski PV, Persky VW, Ramekrishnan V: Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995;95:955–961.
29.
Halonen M, Stern DA, Wright AL, Taussig LM, Martinez FD: Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med 1997;155:1356–1361.
30.
Nelson HS, Szefler SJ, Jacobs J, Huss K, Shapiro G, Sternberg AL: The relationships among environmental allergen sensitization, allergen exposure, pulmonary function, and bronchial hyperresponsiveness in the Childhood Asthma Management Program. J Allergy Clin Immunol 1999;104:775–785.
31.
Peat JK, Tovey E, Mellis CM, Leeder SR, Woolcock AJ: Importance of house dust mite and Alternaria allergens in childhood asthma: an epidemiological study in two climatic regions of Australia. Clin Exp Allergy 1993;23:812–820.
32.
Black PN, Udy AA, Brodie SM: Sensitivity to fungal allergens is a risk factor for life-threatening asthma. Allergy 2000;55:501–504.
33.
O’Driscoll BR, Hopkinson LC, Denning DW: Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions. BMC Pulm Med 2005;5:4.
34.
Reed CE: What we do and do not know about mold allergy and asthma. J Allergy Clin Immunol 1985;76:773–775.
35.
Dales RE, Cakmak S, Judek S, Dann T, Coates F, Brook JR, Burnett RT: The role of fungal spores in thunderstorm asthma. Chest 2003;123:745–750.
36.
O’Hollaren MT, Yunginger JW, Offord KP, Somers MJ, O’Connell EJ, Ballard DJ, Sachs MI: Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991;324:359–363.
37.
Bush RK, Prochnau JJ: Alternaria-induced asthma. J Allergy Clin Immunol 2004;113:227–234.
38.
Neukirch C, Henry C, Leynaert B, Liard R, Bousquet J, Neukirch F: Is sensitization to Alternaria alternata a risk factor for severe asthma? A population-based study. J Allergy Clin Immunol 1999;103:709–711.
39.
Niedoszytko M, Chelminska M, Jassem E, Czestochowska E: Association between sensitization to Aureobasidium pullulans (Pullularia sp) and severity of asthma. Ann Allergy Asthma Immunol 2007;98:153–156.
40.
Leung DY: Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860–876.
41.
Kieffer M, Bergbrant IM, Faergemann J, Jemec GB, Ottevanger V, Stahl Skov P, Svejgaard E: Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol 1990;22:739–742.
42.
Gfesser M, Abeck D, Rugemer J, Schreiner V, Stab F, Disch R, Ring J: The early phase of epidermal barrier regeneration is faster in patients with atopic eczema. Dermatology 1997;195:332–336.
43.
Walker C, Kagi MK, Ingold P, Braun P, Blaser K, Bruijnzeel-Koomen CA, Wuthrich B: Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy 1993;23:145–153.
44.
Schmid-Grendelmeier P, Fluckiger S, Disch R, Trautmann A, Wuthrich B, Blaser K, Scheynius A, Crameri R: IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol 2005;115:1068–1075.
45.
Kortekangas-Savolainen O, Lammintausta K, Kalimo K: Skin prick test reactions to brewer’s yeast (Saccharomyces cerevisiae) in adult atopic dermatitis patients. Allergy 1993;48:147–150.
46.
Mari A, Schneider P, Wally V, Breitenbach M, Simon-Nobbe B: Sensitization to fungi: epidemiology, comparative skin tests, and IgE reactivity of fungal extracts. Clin Exp Allergy 2003;33:1429–1438.
47.
Eggleston PA, Rosenstreich D, Lynn H, Gergen P, Baker D, Kattan M, Mortimer KM, Mitchell H, Ownby D, Slavin R, Malveaux F: Relationship of indoor allergen exposure to skin test sensitivity in inner-city children with asthma. J Allergy Clin Immunol 1998;102:563–570.
48.
Achatz G, Oberkofler H, Lechenauer E, Simon B, Unger A, Kandler D, Ebner C, Prillinger H, Kraft D, Breitenbach M: Molecular cloning of major and minor allergens of Alternaria alternata and Cladosporium herbarum. Mol Immunol 1995;32:213–227.
49.
Simon-Nobbe B, Denk U, Schneider PB, Radauer C, Teige M, Crameri R, Hawranek T, Lang R, Richter K, Schmid-Grendelmeier P, Nobbe S, Hartl A, Breitenbach M: NADP-dependent mannitol dehydrogenase, a major allergen of Cladosporium herbarum. J Biol Chem 2006;281:16354–16360.
50.
Schneider PB, Denk U, Breitenbach M, Richter K, Schmid-Grendelmeier P, Nobbe S, Himly M, Mari A, Ebner C, Simon-Nobbe B: Alternaria alternata NADP-dependent mannitol dehydrogenase is an important fungal allergen. Clin Exp Allergy 2006;36:1513–1524.
51.
Breitenbach M, Simon B, Probst G, Oberkofler H, Ferreira F, Briza P, Achatz G, Unger A, Ebner C, Kraft D, Hirschwehr R: Enolases are highly conserved fungal allergens. Int Arch Allergy Immunol 1997;113:114–117.
52.
Simon-Nobbe B, Probst G, Kajava AV, Oberkofler H, Susani M, Crameri R, Ferreira F, Ebner C, Breitenbach M: IgE-binding epitopes of enolases, a class of highly conserved fungal allergens. J Allergy Clin Immunol 2000;106:887–895.
53.
Zhang L, Muradia G, De Vouge MW, Rode H, Vijay HM: An allergenic polypeptide representing a variable region of hsp 70 cloned from a cDNA library of Cladosporium herbarum. Clin Exp Allergy 1996;26:88–95.
54.
Asturias JA, Ibarrola I, Ferrer A, Andreu C, Lopez-Pascual E, Quiralte J, Florido F, Martinez A: Diagnosis of Alternaria alternata sensitization with natural and recombinant Alt a 1 allergens. J Allergy Clin Immunol 2005;115:1210–1217.
55.
Curran IH, Young NM, Burton M, Vijay HM: Purification and characterization of Alt a-29 from Alternaria alternata. Int Arch Allergy Immunol 1993;102:267–275.
56.
De Vouge MW, Thaker AJ, Zhang L, Muradia G, Rode H, Vijay HM: Molecular cloning of IgE-binding fragments of Alternaria alternata allergens. Int Arch Allergy Immunol 1998;116:261–268.
57.
Zhang L, Curran IH, Muradia G, De Vouge MW, Rode H, Vijay HM: N-terminus of a major allergen, Alt a I, of Alternaria alternata defined to be an epitope. Int Arch Allergy Immunol 1995;108:254–259.
58.
Unger A, Stoger P, Simon-Nobbe B, Susani M, Crameri R, Ebner C, Hintner H, Breitenbach M: Clinical testing of recombinant allergens of the mold Alternaria alternata. Int Arch Allergy Immunol 1999;118:220–221.
59.
Bush RK, Sanchez H, Geisler D: Molecular cloning of a major Alternaria alternata allergen, rAlt a 2. J Allergy Clin Immunol 1999;104:665–671.
60.
Kurup VP, Vijay HM, Kumar V, Castillo L, Elms N: IgE binding synthetic peptides of Alt a 1, a major allergen of Alternaria alternata. Peptides 2003;24:179–185.
61.
Breitenbach M, Simon-Nobbe B: The allergens of Cladosporium herbarum and Alternaria alternata. Chem Immunol 2002;81:48–72.
62.
Breitenbach M, Simon Nobbe B, Denk U, Schneider P, Richter K, Teige M, Radauer C, Ebner C, Nobbe S, Schmid-Grendelmeier P, Crameri R: Cloning, expression, characterization, and skin prick testing of NADPH-dependent mannitol dehydrogenase. A new major allergen of Cladosporium herbarum; in Lowenstein H, Bienenstock J, Ring J (eds): From Genes to Phenotypes – The Basis of Future Allergy Managment. Cambridge, Hogrefe & Huber, 2005, pp 75–77.
63.
Chou H, Tam MF, Lee SS, Tai HY, Chang CY, Chou CT, Shen HD: A vacuolar serine protease (Rho m 2) is a major allergen of Rhodotorula mucilaginosa and belongs to a class of highly conserved pan-fungal allergens. Int Arch Allergy Immunol 2005;138:134–141.
64.
Simon-Nobbe B, Kodzius R, Kajava AV, Ferreira F, Kungl A, Achatz G, Crameri R, Ebner C, Breitenbach M: Structure of an IgE-binding peptide from fungal enolases. Int Arch Allergy Immunol 2001;124:93–94.
65.
Horner WE, Helbling A, Salvaggio JE, Lehrer SB: Fungal allergens. Clin Microbiol Rev 1995;8:161–179.
66.
Terr AI: Are indoor molds causing a new disease? J Allergy Clin Immunol 2004;113:221–226.
67.
Kurup VP, Shen HD, Banerjee B: Respiratory fungal allergy. Microbes Infect 2000;2:1101–1110.
68.
Kurup VP, Banerjee B: Fungal allergens and peptide epitopes. Peptides 2000;21:589–599.
69.
Vijay HM, Kurup VP: Fungal allergens. Clin Allergy Immunol 2004;18:223–249.
70.
Crameri R, Blaser K: Cloning Aspergillus fumigatus allergens by the pJuFo filamentous phage display system. Int Arch Allergy Immunol 1996;110:41–45.
71.
Arruda LK, Mann BJ, Chapman MD: Selective expression of a major allergen and cytotoxin, Asp f I, in Aspergillus fumigatus. Implications for the immunopathogenesis of Aspergillus-related diseases. J Immunol 1992;149:3354–3359.
72.
Banerjee B, Kurup VP, Greenberger PA, Hoffman DR, Nair DS, Fink JN: Purification of a major allergen, Asp f 2 binding to IgE in allergic bronchopulmonary aspergillosis, from culture filtrate of Aspergillus fumigatus. J Allergy Clin Immunol 1997;99:821–827.
73.
Crameri R: Recombinant Aspergillus fumigatus allergens: from the nucleotide sequences to clinical applications. Int Arch Allergy Immunol 1998;115:99–114.
74.
Vailes L, Sridhara S, Cromwell O, Weber B, Breitenbach M, Chapman M: Quantitation of the major fungal allergens, Alt a 1 and Asp f 1, in commercial allergenic products. J Allerg Clin Immunol 2001;107:641–646.
75.
Crameri R, Weichel M, Fluckiger S, Glaser AG, Rhyner C: Fungal allergies: a yet unsolved problem. Chem Immunol Allergy 2006;91:121–133.
76.
Crameri R, Hemmann S, Mayer C, Appenzeller U, Blaser K: Molecular aspects and diagnostic value of fungal allergens (in German). Mycoses 1998;41:56–60.
77.
Moser M, Crameri R, Menz G, Schneider T, Dudler T, Virchow C, Gmachl M, Blaser K, Suter M: Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f I/a) with IgE binding and type I skin test activity. J Immunol 1992;149:454–460.
78.
Kurup VP, Banerjee B, Murali PS, Greenberger PA, Krishnan M, Hari V, Fink JN: Immunodominant peptide epitopes of allergen, Asp f 1 from the fungus Aspergillus fumigatus. Peptides 1998;19:1469–1477.
79.
Moser M, Crameri R, Brust E, Suter M, Menz G: Diagnostic value of recombinant Aspergillus fumigatus allergen I/a for skin testing and serology. J Allergy Clin Immunol 1994;93:1–11.
80.
Chauhan B, Santiago L, Kirschmann DA, Hauptfeld V, Knutsen AP, Hutcheson PS, Woulfe SL, Slavin RG, Schwartz HJ, Bellone CJ: The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol 1997;159:4072–4076.
81.
Banerjee B, Greenberger PA, Fink JN, Kurup VP: Conformational and linear B-cell epitopes of Asp f 2, a major allergen of Aspergillus fumigatus, bind differently to immunoglobulin E antibody in the sera of allergic bronchopulmonary aspergillosis patients. Infect Immun 1999;67:2284–2291.
82.
Tang B, Banerjee B, Greenberger PA, Fink JN, Kelly KJ, Kurup VP: Antibody binding of deletion mutants of Asp f 2, the major Aspergillus fumigatus allergen. Biochem Biophys Res Commun 2000;270:1128–1135.
83.
Rathore VB, Johnson B, Fink JN, Kelly KJ, Greenberger PA, Kurup VP: T cell proliferation and cytokine secretion to T cell epitopes of Asp f 2 in ABPA patients. Clin Immunol 2001;100:228–235.
84.
Hemmann S, Blaser K, Crameri R: Allergens of Aspergillus fumigatus and Candida boidinii share IgE-binding epitopes. Am J Respir Crit Care Med 1997;156:1956–1962.
85.
Hemmann S, Ismail C, Blaser K, Menz G, Crameri R: Skin-test reactivity and isotype-specific immune responses to recombinant Asp f 3, a major allergen of Aspergillus fumigatus. Clin Exp Allergy 1998;28:860–867.
86.
Ramachandran H, Jayaraman V, Banerjee B, Greenberger PA, Kelly KJ, Fink JN, Kurup VP: IgE binding conformational epitopes of Asp f 3, a major allergen of Aspergillus fumigatus. Clin Immunol 2002;103:324–333.
87.
Ramachandran H, Banerjee B, Greenberger PA, Kelly KJ, Fink JN, Kurup VP: Role of C-terminal cysteine residues of Aspergillus fumigatus allergen Asp f 4 in immunoglobulin E binding. Clin Diagn Lab Immunol 2004;11:261–265.
88.
Crameri R, Faith A, Hemmann S, Jaussi R, Ismail C, Menz G, Blaser K: Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus. J Exp Med 1996;184:265–270.
89.
Hemmann S, Menz G, Ismail C, Blaser K, Crameri R: Skin test reactivity to 2 recombinant Aspergillus fumigatus allergens in A fumigatus-sensitized asthmatic subjects allows diagnostic separation of allergic bronchopulmonary aspergillosis from fungal sensitization. J Allergy Clin Immunol 1999;104:601–607.
90.
Kurup VP, Banerjee B, Hemmann S, Greenberger PA, Blaser K, Crameri R: Selected recombinant Aspergillus fumigatus allergens bind specifically to IgE in ABPA. Clin Exp Allergy 2000;30:988–993.
91.
Mayer C, Appenzeller U, Seelbach H, Achatz G, Oberkofler H, Breitenbach M, Blaser K, Crameri R: Humoral and cell-mediated autoimmune reactions to human acidic ribosomal P2 protein in individuals sensitized to Aspergillus fumigatus P2 protein. J Exp Med 1999;189:1507–1512.
92.
Kumar A, Reddy LV, Sochanik A, Kurup VP: Isolation and characterization of a recombinant heat shock protein of Aspergillus fumigatus. J Allergy Clin Immunol 1993;91:1024–1030.
93.
Shen HD, Tam MF, Chou H, Han SH: The importance of serine proteinases as aeroallergens associated with asthma. Int Arch Allergy Immunol 1999;119:259–264.
94.
Shen HD, Lin WL, Tam MF, Wang SR, Tzean SS, Huang MH, Han SH: Characterization of allergens from Penicillium oxalicum and P. notatum by immunoblotting and N-terminal amino acid sequence analysis. Clin Exp Allergy 1999;29:642–651.
95.
Chow LP, Liu SL, Yu CJ, Liao HK, Tsai JJ, Tang TK: Identification and expression of an allergen Asp f 13 from Aspergillus fumigatus and epitope mapping using human IgE antibodies and rabbit polyclonal antibodies. Biochem J 2000;346:423–431.
96.
Lai HYL, Tam MF, Tang RB, Chou H, Chang CY, Tsai JJ, Shen HS: cDNA cloning and immunological characterization of a newly identified enolase allergen from Penicillium citrinum and Aspergillus fumigatus. Int Arch Allergy Immunol 2002;127:181–190.
97.
Bowyer P, Denning DW: Genomic analysis of allergen genes in Aspergillus spp: the relevance of genomics to everyday research. Med Mycol 2007;45:17–26.
98.
Wei DL, Jong SC, Shen HD: Indoor airborne Penicillium species in Taiwan. Curr Microbiol 1993;26:137–140.
99.
Muilenberg M, Burge HA, Sweet T, Solomon W: Penicillium species in and out of doors in Topeka, KS. J Allergy Clin Immunol 1990;85:247.
100.
Licorish K, Novey HS, Kozak P, Fairshter RD, Wilson AF: Role of Alternaria and Penicillium spores in the pathogenesis of asthma. J Allergy Clin Immunol 1985;76:819–825.
101.
Hsieh KH: A study of intracutaneous skin tests and radioallergosorbent tests on 1,000 asthmatic children in Taiwan. Asian Pac J Allergy Immunol 1984;2:56–60.
102.
Chow LP, Su NY, Yu CJ, Chiang BL, Shen HD: Identification and expression of Pen c 2, a novel allergen from Penicillium citrinum. Biochem J 1999;341:51–59.
103.
Shen HD, Au LC, Lin WL, Liaw SF, Tsai JJ, Han SH: Molecular cloning and expression of a Penicillium citrinum allergen with sequence homology and antigenic crossreactivity to a hsp 70 human heat shock protein. Clin Exp Allergy 1997;27:682–690.
104.
Shen HD, Wang CW, Lin WL, Lai HY, Tam MF, Chou H, Wang SR, Han SH: cDNA cloning and immunologic characterization of Pen o 18, the vacuolar serine protease major allergen of Penicillium oxalicum. J Lab Clin Med 2001;137:115–124.
105.
Lai HY, Tam MF, Chou H, Lee SS, Tai HY, Shen HD: Molecular and structural analysis of immunoglobulin E-binding epitopes of Pen ch 13, an alkaline serine protease major allergen from Penicillium chrysogenum. Clin Exp Allergy 2004;34:1926–1933.
106.
Shen HD, Chou H, Tam MF, Chang CY, Lai HY, Wang SR: Molecular and immunological characterization of Pen ch 18, the vacuolar serine protease major allergen of Penicillium chrysogenum. Allergy 2003;58:993–1002.
107.
Yu CJ, Chen YM, Su SN, Forouhar F, Lee SH, Chow LP: Molecular and immunological characterization and IgE epitope mapping of Pen n 18, a major allergen of Penicillium notatum. Biochem J 2002;363:707–715.
108.
Shen HD, Wang CW, Chou H, Lin WL, Tam MF, Huang MH, Kuo ML, Wang SR, Han SH: Complementary DNA cloning and immunologic characterization of a new Penicillium citrinum allergen (Pen c 3). J Allergy Clin Immunol 2000;105:827–833.
109.
Sevinc MS, Kumar V, Abebe M, Casley WL, Vijay HM: Isolation and characterization of a cDNA clone encoding one IgE-binding fragment of Penicillium brevicompactum. Int Arch Allergy Immunol 2005;138:12–20.
110.
Tang RB, Chen YS, Chou H, Lee SS, Tai HY, Shen HD: cDNA cloning and immunologic characterization of a novel EF-1β allergen from Penicillium citrinum. Allergy 2005;60:366–371.
111.
Akiyama K, Shida T, Yasueda H, Mita H, Yanagihara Y, Hasegawa M, Maeda Y, Yamamoto T, Takesako K, Yamaguchi H: Allergenicity of acid protease secreted by Candida albicans. Allergy 1996;51:887–892.
112.
Martinez JP, Gil ML, Lopez-Ribot JL, Chaffin WL: Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin Microbiol Rev 1998;11:121–141.
113.
Ito K, Ishiguro A, Kanbe T, Tanaka K, Torii S: Characterization of IgE-binding epitopes on Candida albicans enolase. Clin Exp Allergy 1995;25:529–535.
114.
Eroles P, Sentandreu M, Elorza MV, Sentandreu R: The highly immunogenic enolase and Hsp70p are adventitious Candida albicans cell wall proteins. Microbiology 1997;143(Pt 2):313–320.
115.
Burge HA, Solomon WR, Muilenberg ML: Evaluation of indoor plantings as allergen exposure sources. J Allergy Clin Immunol 1982;70:101–108.
116.
Levetin E: Studies on airborne basidiospores. Aerobiologia 1990;6:177–180.
117.
Luo W: Deposition of large particles in the nose and mouth. Grana 1991;30:79–81.
118.
Roncarolo D, Minale P, Mistrello G, Voltolini S, Falagiani P: Food allergy to Boletus edulis. J Allergy Clin Immunol 1998;101:850–851.
119.
Levy AM, Kita H, Phillips SF, Schkade PA, Dyer PD, Gleich GJ, Dubravec VA: Eosinophilia and gastrointestinal symptoms after ingestion of shiitake mushrooms. J Allergy Clin Immunol 1998;101:613–620.
120.
Epton MJ, Martin IR, Graham P, Healy PE, Smith H, Balasubramaniam R, Harvey IC, Fountain DW, Hedley J, Town GI: Climate and aeroallergen levels in asthma: a 12 month prospective study. Thorax 1997;52:528–534.
121.
Brander KA, Borbely P, Crameri R, Pichler WJ, Helbling A: IgE-binding proliferative responses and skin test reactivity to Cop c 1, the first recombinant allergen from the basidiomycete Coprinus comatus. J Allergy Clin Immunol 1999;104:630–636.
122.
Lehrer SB, Hughes JM, Altman LC, Bousquet J, Davies RJ, Gell L, Li J, Lopez M, Malling HJ, Mathison DA, et al: Prevalence of basidiomycete allergy in the USA and Europe and its relationship to allergic respiratory symptoms. Allergy 1994;49:460–465.
123.
Helbling A, Gayer F, Pichler WJ, Brander KA: Mushroom (Basidiomycete) allergy: diagnosis established by skin test and nasal challenge. J Allergy Clin Immunol 1998;102:853–858.
124.
Helbling A, Brander KA, Horner WE, Lehrer SB: Allergy to basidiomycetes. Chem Immunol 2002;81:28–47.
125.
Faergemann J, Fredriksson T: Age incidence of Pityrosporum orbiculare on human skin. Acta Derm Venereol 1980;60:531–533.
126.
Faergemann J, Aly R, Maibach HI: Quantitative variations in distribution of Pityrosporum orbiculare on clinically normal skin. Acta Derm Venereol 1983;63:346–348.
127.
Lintu P, Savolainen J, Kalimo K: IgE antibodies to protein and mannan antigens of Pityrosporum ovale in atopic dermatitis patients. Clin Exp Allergy 1997;27:87–95.
128.
Johansson S, Karlstrom K: IgE-binding components in Pityrosporum orbiculare identified by an immunoblotting technique. Acta Derm Venereol 1991;71:11–16.
129.
Garrard LJ, Goodman JM: Two genes encode the major membrane-associated protein of methanol-induced peroxisomes from Candida boidinii. J Biol Chem 1989;264:13929–13937.
130.
Yasueda H, Hashida-Okado T, Saito A, Uchida K, Kuroda M, Onishi Y, Takahashi K, Yamaguchi H, Takesako K, Akiyama K: Identification and cloning of two novel allergens from the lipophilic yeast, Malassezia furfur. Biochem Biophys Res Commun 1998;248:240–244.
131.
Lindborg M, Magnusson CG, Zargari A, Schmidt M, Scheynius A, Crameri R, Whitley P: Selective cloning of allergens from the skin colonizing yeast Malassezia furfur by phage surface display technology. J Invest Dermatol 1999;113:156–161.
132.
Onishi Y, Kuroda M, Yasueda H, Saito A, Sono-Koyama E, Tunasawa S, Hashida-Okado T, Yagihara T, Uchida K, Yamaguchi H, Akiyama K, Kato I, Takesako K: Two-dimensional electrophoresis of Malassezia allergens for atopic dermatitis and isolation of Mal f 4 homologs with mitochondrial malate dehydrogenase. Eur J Biochem 1999;261:148–154.
133.
Andersson A, Rasool O, Schmidt M, Kodzius R, Fluckiger S, Zargari A, Crameri R, Scheynius A: Cloning, expression and characterization of two new IgE-binding proteins from the yeast Malassezia sympodialis with sequence similarities to heat shock proteins and manganese superoxide dismutase. Eur J Biochem 2004;271:1885–1894.
134.
Nierman WC, Pain A, Anderson MJ, et al: Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus. Nature 2005;438:1151–1156.
135.
Helbling A, Horner WE, Lehrer SB: Comparison of Psilocybe cubensis spore and mycelium allergens. J Allergy Clin Immunol 1993;91:1059–1066.
136.
Horner WE, Reese G, Lehrer SB: Identification of the allergen Psi c 2 from the basidiomycete Psilocybe cubensis as a fungal cyclophilin. Int Arch Allergy Immunol 1995;107:298–300.
137.
Chang CY, Chou H, Tam MF, Tang RB, Lai HY, Shen HD: Characterization of enolase allergen from Rhodotorula mucilaginosa. J Biomed Sci 2002;9:645–655.
138.
Aalberse RC, Akkerdaas J, van Ree R: Cross-reactivity of IgE antibodies to allergens. Allergy 2001;56:478–490.
139.
Aalberse RC: Structural biology of allergens. J Allergy Clin Immunol 2000;106:228–238.
140.
O’Neil CE, Horner WE, Reed MA, Lopez M, Lehrer SB: Evaluation of Basidiomycete and Deuteromycete (Fungi Imperfecti) extracts for shared allergenic determinants. Clin Exp Allergy 1990;20:533–538.
141.
Saenz-de-Santamaria M, Postigo I, Gutierrez-Rodriguez A, Cardona G, Guisantes JA, Asturias J, Martinez J: The major allergen of Alternaria alternata (Alt a 1) is expressed in other members of the Pleosporaceae family. Mycoses 2006;49:91–95.
142.
Lin WL, Chou H, Tam MF, Huang MH, Han SH, Shen HD: Production and characterization of monoclonal antibodies to serine proteinase allergens in Penicillium and Aspergillus species. Clin Exp Allergy 2000;30:1653–1662.
143.
Simon-Nobbe B, Pöll V, Wally V, Shen HD, Lottspeich F, Hawranek T, Lang R, Hemmer W, Jarisch R, Breitenbach M: Vacuolar serine proteases from Cladosporium herbarum and Alternaria alternata, submitted.
144.
Gupta R, Singh BP, Sridhara S, Gaur SN, Kumar R, Chaudhary VK, Arora N: Allergenic cross-reactivity of Curvularia lunata with other airborne fungal species. Allergy 2002;57:636–640.
145.
Karkkainen M, Raunio P, Rautiainen J, Auriola S, Hinke K, Pasanen AL: Partial amino acid sequence of a cellulase-like component with IgE-binding properties from Stachybotrys chartarum. Int Arch Allergy Immunol 2004;133:136–144.
146.
Wagner S, Breiteneder H, Simon-Nobbe B, Susani M, Krebitz M, Niggemann B, Brehler R, Scheiner O, Hoffmann-Sommergruber K: Hev b 9, an enolase and a new cross-reactive allergen from Hevea latex and molds. Purification, characterization, cloning and expression. Eur J Biochem 2000;267:7006–7014.
147.
Shankar J, Gupta PD, Sridhara S, Singh BP, Gaur SN, Arora N: Immunobiochemical analysis of cross-reactive glutathione-S-transferase allergen from different fungal sources. Immunol Invest 2005;34:37–51.
148.
Fluckiger S, Scapozza L, Mayer C, Blaser K, Folkers G, Crameri R: Immunological and structural analysis of IgE-mediated cross-reactivity between manganese superoxide dismutases. Int Arch Allergy Immunol 2002;128:292–303.
149.
Wagner S, Sowka S, Mayer C, Crameri R, Focke M, Kurup VP, Scheiner O, Breiteneder H: Identification of a Hevea brasiliensis latex manganese superoxide dismutase (Hev b 10) as a cross-reactive allergen. Int Arch Allergy Immunol 2001;125:120–127.
150.
Glaser AG, Limacher A, Fluckiger S, Scheynius A, Scapozza L, Crameri R: Analysis of the cross-reactivity and of the 1.5 A crystal structure of the Malassezia sympodialis Mala s 6 allergen, a member of the cyclophilin pan-allergen family. Biochem J 2006;396:41–49.
151.
Appenzeller U, Meyer C, Menz G, Blaser K, Crameri R: IgE-mediated reactions to autoantigens in allergic diseases. Int Arch Allergy Immunol 1999;118:193–196.
152.
Weichel M, Glaser AG, Ballmer-Weber BK, Schmid-Grendelmeier P, Crameri R: Wheat and maize thioredoxins: a novel cross-reactive cereal allergen family related to baker’s asthma. J Allergy Clin Immunol 2006;117:676–681.
153.
Esch RE: Manufacturing and standardizing fungal allergen products. J Allergy Clin Immunol 2004;113:210–215.
154.
Aas K, Leegaard J, Aukrust L, Grimmer O: Immediate type hypersensitivity to common moulds. Comparison of different diagnostic materials. Allergy 1980;35:443–451.
155.
Portnoy J, Chapman J, Burge H, Muilenberg M, Solomon W: Epicoccum allergy: skin reaction patterns and spore/mycelium disparities recognized by IgG and IgE ELISA inhibition. Ann Allergy 1987;59:39–43.
156.
Steringer I, Aukrust L, Einarsson R: Variability of antigenicity/allergenicity in different strains of Alternaria alternata. Int Arch Allergy Appl Immunol 1987;84:190–197.
157.
Paris S, Fitting C, Ramirez E, Latge JP, David B: Comparison of different extraction methods of Alternaria allergens. J Allergy Clin Immunol 1990;85:941–948.
158.
Hoffman DR, Kozak PP Jr, Gillman SA, Cummins LH, Gallup J: Isolation of spore specific allergens from Alternaria. Ann Allergy 1981;46:310–316.
159.
Ferreira F, Wallner M, Thalhamer J: Customized antigens for desensitizing allergic patients. Adv Immunol 2004;84:79–129.
160.
Portnoy J, Pacheco F, Ballam Y, Barnes C: The effect of time and extraction buffers on residual protein and allergen content of extracts derived from four strains of Alternaria. J Allergy Clin Immunol 1993;91:930–938.
161.
Green BJ, Sercombe JK, Tovey ER: Fungal fragments and undocumented conidia function as new aeroallergen sources. J Allergy Clin Immunol 2005;115:1043–1048.
162.
Chapman MD, Smith AM, Vailes LD, Arruda LK, Dhanaraj V, Pomes A: Recombinant allergens for diagnosis and therapy of allergic disease. J Allergy Clin Immunol 2000;106:409–418.
163.
Schmidt M, Hoffman DR: Expression systems for production of recombinant allergens. Int Arch Allergy Immunol 2002;128:264–270.
164.
De Vouge MW, Thaker AJ, Curran IH, Zhang L, Muradia G, Rode H, Vijay HM: Isolation and expression of a cDNA clone encoding an Alternaria alternata Alt a 1 subunit. Int Arch Allergy Immunol 1996;111:385–395.
165.
Schmid-Grendelmeier P, Crameri R: Recombinant allergens for skin testing. Int Arch Allergy Immunol 2001;125:96–111.
166.
Ballmer-Weber BK, Scheurer S, Fritsche P, Enrique E, Cistero-Bahima A, Haase T, Wuthrich B: Component-resolved diagnosis with recombinant allergens in patients with cherry allergy. J Allergy Clin Immunol 2002;110:167–173.
167.
Tresch S, Holzmann D, Baumann S, Blaser K, Wuthrich B, Crameri R, Schmid-Grendelmeier P: In vitro and in vivo allergenicity of recombinant Bet v 1 compared to the reactivity of natural birch pollen extract. Clin Exp Allergy 2003;33:1153–1158.
168.
Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H: The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999;29:896–904.
169.
Mari A: Skin test with a timothy grass (Phleum pratense) pollen extract vs. IgE to a timothy extract vs. IgE to rPhl p 1, rPhl p 2, nPhl p 4, rPhl p 5, rPhl p 6, rPhl p 7, rPhl p 11, and rPhl p 12: epidemiological and diagnostic data. Clin Exp Allergy 2003;33:43–51.
170.
Hiller R, Laffer S, Harwanegg C, et al: Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002;16:414–416.
171.
Vailes LD, Perzanowski MS, Wheatley LM, Platts-Mills TA, Chapman MD: IgE and IgG antibody responses to recombinant Alt a 1 as a marker of sensitization to Alternaria in asthma and atopic dermatitis. Clin Exp Allergy 2001;31:1891–1895.
172.
Ball T, Sperr WR, Valent P, Lidholm J, Spitzauer S, Ebner C, Kraft D, Valenta R: Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Eur J Immunol 1999;29:2026–2036.
173.
Moverare R, Elfman L, Vesterinen E, Metso T, Haahtela T: Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy 2002;57:423–430.
174.
Malling HJ: Immunotherapy for mold allergy. Clin Rev Allergy 1992;10:237–251.
175.
Malling HJ, Dreborg S, Weeke B: Diagnosis and immunotherapy of mould allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum. Allergy 1986;41:507–519.
176.
Dreborg S, Agrell B, Foucard T, Kjellman NI, Koivikko A, Nilsson S: A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy 1986;41:131–140.
177.
Malling HJ: Diagnosis and immunotherapy of mould allergy. With special reference to Cladosporium herbarum. Dan Med Bull 1990;37:12–22.
178.
Cantani A, Businco E, Maglio A: Alternaria allergy: a three-year controlled study in children treated with immunotherapy. Allergol Immunopathol (Madr) 1988;16:1–4.
179.
Ezeamuzie CI, Al-Ali S, Khan M, Hijazi Z, Dowaisan A, Thomson MS, Georgi J: IgE-mediated sensitization to mould allergens among patients with allergic respiratory diseases in a desert environment. Int Arch Allergy Immunol 2000;121:300–307.
180.
Gergen PJ, Turkeltaub PC, Kovar MG: The prevalence of allergic skin test reactivity to eight common aeroallergens in the US population: results from the second National Health and Nutrition Examination Survey. J Allergy Clin Immunol 1987;80:669–679.
181.
D’Amato G, Chatzigeorgiou G, Corsico R, Gioulekas D, Jager L, Jager S, Kontou-Fili K, Kouridakis S, Liccardi G, Meriggi A, Palma-Carlos A, Palma-Carlos ML, Pagan Aleman A, Parmiani S, Puccinelli P, Russo M, Spieksma FT, Torricelli R, Wuthrich B: Evaluation of the prevalence of skin prick test positivity to Alternaria and Cladosporium in patients with suspected respiratory allergy. A European multicenter study promoted by the Subcommittee on Aerobiology and Environmental Aspects of Inhalant Allergens of the European Academy of Allergology and Clinical Immunology. Allergy 1997;52:711–716.
182.
Nolles G, Hoekstra MO, Schouten JP, Gerritsen J, Kauffman HF: Prevalence of immunoglobulin E for fungi in atopic children. Clin Exp Allergy 2001;31:1564–1570.
183.
Gioulekas D, Damialis A, Papakosta D, Spieksma F, Giouleka P, Patakas D: Allergenic fungi spore records (15 years) and sensitization in patients with respiratory allergy in Thessaloniki-Greece. J Investig Allergol Clin Immunol 2004;14:225–231.
184.
Pumihirun P, Towiwat P, Mahakit P: Aeroallergen sensitivity of Thai patients with allergic rhinitis. Asian Pac J Allergy Immunol 1997;15:183–185.
185.
O’Neil CE, McCants ML, Salvaggio JE, Lehrer SB: Fusarium solani: prevalence of skin reactivity and antigenic allergenic analysis. J Allergy Clin Immunol 1986;77:842–849.
186.
Nordvall SL, Johansson S: IgE antibodies to Pityrosporum orbiculare in children with atopic diseases. Acta Paediatr Scand 1990;79:343–348.
187.
Shankar J, Singh BP, Gaur SN, Arora N: Recombinant glutathione-S-transferase a major allergen from Alternaria alternata for clinical use in allergy patients. Mol Immunol 2006;43:1927–1932.
188.
Portnoy J, Olson I, Pacheco F, Barnes C: Affinity purification of a major Alternaria allergen using a monoclonal antibody. Ann Allergy 1990;65:109–114.
189.
Weichel M, Schmid-Grendelmeier P, Fluckiger S, Breitenbach M, Blaser K, Crameri R: Nuclear transport factor 2 represents a novel cross-reactive fungal allergen. Allergy 2003;58:198–206.
190.
Hong SG, Cramer RA, Lawrence CB, Pryor BM: Alt a 1 allergen homologs from Alternaria and related taxa: analysis of phylogenetic content and secondary structure. Fungal Genet Biol 2005;42:119–129.
191.
Cramer RA, Lawrence CB: Cloning of a gene encoding an Alt a 1 isoallergen differentially expressed by the necrotrophic fungus Alternaria brassicicola during Arabidopsis infection. Appl Environ Microbiol 2003;69:2361–2364.
192.
Chou H, Lin W, Tam MF, Wang S, Han S, Shen H: Alkaline serine proteinase is a major allergen of Aspergillus flavus, a prevalent airborne Aspergillus species in the Taipei area. Int Arch Allergy Immunol 1999;119:282–290.
193.
Yu CJ, Chiou SH, Lai WY, Chiang BL, Chow LP: Characterization of a novel allergen, a major IgE-binding protein from Aspergillus flavus, as an alkaline serine protease. Biochem Biophys Res Commun 1999;261:669–675.
194.
Stewart GA, Robinson C: The immunobiology of allergenic peptidases. Clin Exp Allergy 2003;33:3–6.
195.
Hemmann S, Nikolaizik WH, Schoni MH, Blaser K, Crameri R: Differential IgE recognition of recombinant Aspergillus fumigatus allergens by cystic fibrosis patients with allergic bronchopulmonary aspergillosis or Aspergillus allergy. Eur J Immunol 1998;28:1155–1160.
196.
Arruda LK, Platts-Mills TA, Fox JW, Chapman MD: Aspergillus fumigatus allergen I, a major IgE-binding protein, is a member of the mitogillin family of cytotoxins. J Exp Med 1990;172:1529–1532.
197.
Jaton-Ogay K, Paris S, Huerre M, Quadroni M, Falchetto R, Togni G, Latge JP, Monod M: Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus. Mol Microbiol 1994;14:917–928.
198.
Reichard U, Monod M, Ruchel R: Molecular cloning and sequencing of the gene encoding an extracellular aspartic proteinase from Aspergillus fumigatus. FEMS Microbiol Lett 1995;130:69–74.
199.
Fluckiger S, Fijten H, Whitley P, Blaser K, Crameri R: Cyclophilins, a new family of cross-reactive allergens. Eur J Immunol 2002;32:10–17.
200.
Crameri R: Epidemiology and molecular basis of the involvement of Aspergillus fumigatus in allergic diseases. Contrib Microbiol 1999;2:44–56.
201.
Limacher A, Kloer DP, Fluckiger S, Folkers G, Crameri R, Scapozza L: The crystal structure of Aspergillus fumigatus cyclophilin reveals 3D domain swapping of a central element. Structure 2006;14:185–195.
202.
Jaton-Ogay K, Suter M, Crameri R, Falchetto R, Fatih A, Monod M: Nucleotide sequence of a genomic and a cDNA clone encoding an extracellular alkaline protease of Aspergillus fumigatus. FEMS Microbiol Lett 1992;71:163–168.
203.
Arruda LK, Platts-Mills TA, Longbottom JL, el-Dahr JM, Chapman MD: Aspergillus fumigatus: identification of 16, 18, and 45 kd antigens recognized by human IgG and IgE antibodies and murine monoclonal antibodies. J Allergy Clin Immunol 1992;89:1166–1176.
204.
Banerjee B, Kurup VP, Greenberger PA, Johnson BD, Fink JN: Cloning and expression of Aspergillus fumigatus allergen Asp f 16 mediating both humoral and cell-mediated immunity in allergic bronchopulmonary aspergillosis (ABPA). Clin Exp Allergy 2001;31:761–770.
205.
Hemmann S: Cloning, Characterization and Clinical Evaluation of Recombinant Aspergillus fumigatus Allergens; thesis, University of Zürich, 1998.
206.
Saxena S, Madan T, Muralidhar K, Sarma PU: cDNA cloning, expression and characterization of an allergenic L3 ribosomal protein of Aspergillus fumigatus. Clin Exp Immunol 2003;134:86–91.
207.
Nigam S, Ghosh PC, Sarma PU: A new glycoprotein allergen/antigen with the protease activity from Aspergillus fumigatus. Int Arch Allergy Immunol 2003;132:124–131.
208.
Calera JA, Ovejero MC, Lopez-Medrano R, Segurado M, Puente P, Leal F: Characterization of the Aspergillus nidulans aspnd1 gene demonstrates that the ASPND1 antigen, which it encodes, and several Aspergillus fumigatus immunodominant antigens belong to the same family. Infect Immun 1997;65:1335–1344.
209.
Sander I, Raulf-Heimsoth M, Siethoff C, Lohaus C, Meyer HE, Baur X: Allergy to Aspergillus-derived enzymes in the baking industry: identification of beta-xylosidase from Aspergillus niger as a new allergen (Asp n 14). J Allergy Clin Immunol 1998;102:256–264.
210.
Shen HD, Han SH: Characterization of allergens of Penicillium and Aspergillus species. J Microbiol Immunol Infect 1998;31:141–145.
211.
Baur X, Melching-Kollmuss S, Koops F, Strassburger K, Zober A: IgE-mediated allergy to phytase – a new animal feed additive. Allergy 2002;57:943–945.
212.
Doekes G, Kamminga N, Helwegen L, Heederik D: Occupational IgE sensitisation to phytase, a phosphatase derived from Aspergillus niger. Occup Environ Med 1999;56:454–459.
213.
Quirce S, Fernandez-Nieto M, Escudero C, Cuesta J, de Las Heras M, Sastre J: Bronchial responsiveness to bakery-derived allergens is strongly dependent on specific skin sensitivity. Allergy 2006;61:1202–1208.
214.
Quirce S, Fernandez-Nieto M, Bartolome B, Bombin C, Cuevas M, Sastre J: Glucoamylase: another fungal enzyme associated with baker’s asthma. Ann Allergy Asthma Immunol 2002;89:197–202.
215.
Cullinan P, Cook A, Jones M, Cannon J, Fitzgerald B, Taylor AJ: Clinical responses to ingested fungal alpha-amylase and hemicellulase in persons sensitized to Aspergillus fumigatus? Allergy 1997;52:346–349.
216.
Tatsumi H, Ogawa Y, Murakami S, Ishida Y, Murakami K, Masaki A, Kawabe H, Arimura H, Nakano E, Motai H: A full length cDNA clone for the alkaline protease from Aspergillus oryzae: structural analysis and expression in Saccharomyces cerevisiae. Mol Gen Genet 1989;219:33–38.
217.
Smith TA, Parker G, Hussain T: Respiratory symptoms and wheat flour exposure: a study of flour millers. Occup Med 2000;50:25–29.
218.
Biagini RE, MacKenzie BA, Sammons DL, Smith JP, Striley CA, Robertson SK, Snawder JE: Evaluation of the prevalence of antiwheat-, anti-flour dust, and anti-alpha-amylase specific IgE antibodies in US blood donors. Ann Allergy Asthma Immunol 2004;92:649–653.
219.
Moneo I, Alday E, Gonzalez-Munoz M, Maqueda J, Curiel G, Lucena R: α-Amylase hypersensitivity in non-exposed millers. Occup Med (Lond) 1994;44:91–94.
220.
Tsukagoshi N, Furukawa M, Nagaba H, Kirita N, Tsuboi A, Udaka S: Isolation of a cDNA encoding Aspergillus oryzae Taka-amylase A: evidence for multiple related genes. Gene 1989;84:319–327.
221.
Muir DC, Verrall AB, Julian JA, Millman JM, Beaudin MA, Dolovich J: Occupational sensitization to lactase. Am J Ind Med 1997;31:570–571.
222.
Bernstein JA, Bernstein DI, Stauder T, Lummus Z, Bernstein IL: A cross-sectional survey of sensitization to Aspergillus oryzae-derived lactase in pharmaceutical workers. J Allergy Clin Immunol 1999;103:1153–1157.
223.
Binkley KE: Allergy to supplemental lactase enzyme. J Allergy Clin Immunol 1996;97:1414–1416.
224.
Lindstedt M, Schiott A, Johnsen CR, Roggen E, Johansson-Lindbom B, Borrebaeck CA: Individuals with occupational allergy to detergent enzymes display a differential transcriptional regulation and cellular immune response. Clin Exp Allergy 2005;35:199–206.
225.
Westwood GS, Huang SW, Keyhani NO: Molecular and immunological characterization of allergens from the entomopathogenic fungus Beauveria bassiana. Clin Mol Allergy 2006;4:12.
226.
Shen HD, Choo KB, Lee HH, Hsieh JC, Lin WL, Lee WR, Han SH: The 40-kilodalton allergen of Candida albicans is an alcohol dehydrogenase: molecular cloning and immunological analysis using monoclonal antibodies. Clin Exp Allergy 1991;21:675–681.
227.
Chou H, Tam MF, Chang CY, Lai HY, Huang MH, Chou CT, Lee SS, Shen HD: Characterization of a novel Candida albicans 29 kDa IgE-binding protein – purification, cDNA isolation and heterologous expression of Cand a 3. Allergy 2003;58:1157–1164.
228.
Asako Y, Saito A, Yasueda H, Kawaguchi H, Akiyama K, Endo M, Onishi Y, Takesako K: Analysis of IgE reactivities of purified allergens from Candida albicans and Malassezia furfur among patients with atopic dermatitis (in Japanese). Arerugi 2002;51:615–621.
229.
Ito K, Ishiguro A, Kanbe T, Tanaka K, Torii S: Detection of IgE antibody against Candida albicans enolase and its crossreactivity to Saccharomyces cerevisiae enolase. Clin Exp Allergy 1995;25:522–528.
230.
Mason AB, Buckley HR, Gorman JA: Molecular cloning and characterization of the Candida albicans enolase gene. J Bacteriol 1993;175:2632–2639.
231.
Ishiguro A, Homma M, Torii S, Tanaka K: Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera. Infect Immun 1992;60:1550–1557.
232.
al-Dughaym AM, Matthews RC, Burnie JP: Epitope mapping human heat shock protein 90 with sera from infected patients. FEMS Immunol Med Microbiol 1994;8:43–48.
233.
Muthuvel A, Rajamani R, Senthilvelan M, Manikandan S, Sheeladevi R: Modification of allergenicity and immunogenicity of formate dehydrogenase by conjugation with linear mono methoxy poly ethylene glycol: improvement in detoxification of formate in methanol poisoning. Clin Chim Acta 2006;374:122–128.
234.
Aukrust L, Borch SM: Partial purification and characterization of two Cladosporium herbarum allergens. Int Arch Allergy Appl Immunol 1979;60:68–79.
235.
Zhang L, Muradia G, Curran IH, Rode H, Vijay HM: A cDNA clone coding for a novel allergen, Cla h III, of Cladosporium herbarum identified as a ribosomal P2 protein. J Immunol 1995;154:710–717.
236.
Kurup VP, Shen HD, Vijay H: Immunobiology of fungal allergens. Int Arch Allergy Immunol 2002;129:181–188.
237.
Falsone SF, Weichel M, Crameri R, Breitenbach M, Kungl AJ: Unfolding and double-stranded DNA binding of the cold shock protein homologue Cla h 8 from Cladosporium herbarum. J Biol Chem 2002;277:16512–16516.
238.
Weichel M, Schmid-Grendelmeier P, Rhyner C, Achatz G, Blaser K, Crameri R: Immunoglobulin E-binding and skin test reactivity to hydrophobin HCh-1 from Cladosporium herbarum, the first allergenic cell wall component of fungi. Clin Exp Allergy 2003;33:72–77.
239.
Gupta R, Sharma V, Sridhara S, Singh BP, Arora N: Identification of serine protease as a major allergen of Curvularia lunata. Allergy 2004;59:421–427.
240.
Sharma V, Gupta R, Jhingran A, Singh BP, Sridhara S, Gaur SN, Arora N: Cloning, recombinant expression and activity studies of a major allergen ‘enolase’ from the fungus Curvularia lunata. J Clin Immunol 2006;26:360–369.
241.
Bisht V, Arora N, Singh BP, Pasha S, Gaur SN, Sridhara S: Epi p 1, an allergenic glycoprotein of Epicoccum purpurascens is a serine protease. FEMS Immunol Med Microbiol 2004;42:205–211.
242.
Hoff M, Ballmer-Weber BK, Niggemann B, Cistero-Bahima A, San Miguel-Moncin M, Conti A, Haustein D, Vieths S: Molecular cloning and immunological characterisation of potential allergens from the mould Fusarium culmorum. Mol Immunol 2003;39:965–975.
243.
Verma J, Pasha S, Gangal SV: Purification and characterization of Fus sI3596*, a 65 kd allergen of Fusarium solani. Mol Cell Biochem 1994;131:157–166.
244.
Verma J, Singh BP, Sridhara S, Gaur SN, Arora N: Purification and characterization of a cross-reactive 45-kD major allergen of Fusarium solani. Int Arch Allergy Immunol 2003;130:193–199.
245.
Shen HD, Lin WL, Tsai JJ, Liaw SF, Han SH: Allergenic components in three different species of Penicillium: crossreactivity among major allergens. Clin Exp Allergy 1996;26:444–451.
246.
Chou H, Chang CY, Tsai JJ, Tang RB, Lee SS, Wang SR, Peng HJ, Shen HD: The prevalence of IgE antibody reactivity against the alkaline serine protease major allergen of Penicillium chrysogenum increases with the age of asthmatic patients. Ann Allergy Asthma Immunol 2003;90:248–253.
247.
Shen HD, Liaw SF, Lin WL, Ro LH, Yang HL, Han SH: Molecular cloning of cDNA coding for the 68 kDa allergen of Penicillium notatum using MoAbs. Clin Exp Allergy 1995;25:350–356.
248.
Su NY, Yu CJ, Shen HD, Pan FM, Chow LP: Pen c 1, a novel enzymic allergen protein from Penicillium citrinum. Purification, characterization, cloning and expression. Eur J Biochem 1999;261:115–123.
249.
Nittner-Marszalska M, Wojcicka-Kustrzeba I, Bogacka E, Patkowski J, Dobek R: Skin prick test response to enzyme enolase of the baker’s yeast (Saccharomyces cerevisiae) in diagnosis of respiratory allergy. Med Sci Monit 2001;7:121–124.
250.
Holland MJ, Holland JP, Thill GP, Jackson KA: The primary structures of two yeast enolase genes. Homology between the 5′ noncoding flanking regions of yeast enolase and glyceraldehyde-3-phosphate dehydrogenase genes. J Biol Chem 1981;256:1385–1395.
251.
Vojdani A: Antibodies against Stachybotrys chartarum extract and its antigenic components, Stachyhemolysin and Stachyrase-A: a new clinical biomarker. Med Sci Monit 2005;11:BR139–BR145.
252.
Jakobsen CG, Bodtger U, Kristensen P, Poulsen LK, Roggen EL: Isolation of high-affinity human IgE and IgG antibodies recognising Bet v 1 and Humicola lanuginosa lipase from combinatorial phage libraries. Mol Immunol 2004;41:941–953.
253.
Woodfolk JA, Wheatley LM, Piyasena RV, Benjamin DC, Platts-Mills TA: Trichophyton antigens associated with IgE antibodies and delayed type hypersensitivity. Sequence homology to two families of serine proteinases. J Biol Chem 1998;273:29489–29496.
254.
Deuell B, Arruda LK, Hayden ML, Chapman MD, Platts-Mills TA: Trichophyton tonsurans allergen. I. Characterization of a protein that causes immediate but not delayed hypersensitivity. J Immunol 1991;147:96–101.
255.
Zargari A, Schmidt M, Lundberg M, Scheynius A, Whitley P: Immunologic characterization of natural and recombinant Mal f 1 yeast allergen. J Allergy Clin Immunol 1999;103:877–884.
256.
Johansson C, Eshaghi H, Linder MT, Jakobson E, Scheynius A: Positive atopy patch test reaction to Malassezia furfur in atopic dermatitis correlates with a T helper 2-like peripheral blood mononuclear cells response. J Invest Dermatol 2002;118:1044–1051.
257.
Schmidt M, Zargari A, Holt P, Lindbom L, Hellman U, Whitley P, van der Ploeg I, Harfast B, Scheynius A: The complete cDNA sequence and expression of the first major allergenic protein of Malassezia furfur, Mal f 1. Eur J Biochem 1997;246:181–185.
258.
Rasool O, Zargari A, Almqvist J, Eshaghi H, Whitley P, Scheynius A: Cloning, characterization and expression of complete coding sequences of three IgE binding Malassezia furfur allergens, Mal f 7, Mal f 8 and Mal f 9. Eur J Biochem 2000;267:4355–4361.
259.
Johansson C, Tengvall Linder M, Aalberse RC, Scheynius A: Elevated levels of IgG and IgG4 to Malassezia allergens in atopic eczema patients with IgE reactivity to Malassezia. Int Arch Allergy Immunol 2004;135:93–100.
260.
Casagrande BF, Fluckiger S, Linder MT, Johansson C, Scheynius A, Crameri R, Schmid-Grendelmeier P: Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema. J Invest Dermatol 2006;126:2414–2421.
261.
Zargari A, Selander C, Rasool O, Ghanem M, Gadda G, Crameri R, Scheynius A: Mala s 12 is a major allergen in patients with atopic eczema and has sequence similarities to the GMC oxidoreductase family. Allergy 2007;62:695–703.
262.
Croce MA, da Costa Manso ER, Gambale W, Takayama L, Oliveira Andrade CE, Pereira Pinto JH, Morato Castro FF, Croce J: Sensitization to the fungus Hemileia vastatrix (coffee leaf rust). Allergy 2001;56:684–687.
263.
Barnes C, Buckley S, Pacheco F, Portnoy J: IgE-reactive proteins from Stachybotrys chartarum. Ann Allergy Asthma Immunol 2002;89:29–33
264.
Mungan D, Bavbek S, Peksari V, Celik G, Gugey E, Misirligil Z: Trichophyton sensitivity in allergic and nonallergic asthma. Allergy 2001;56:558–562.
265.
Green B, Blachere F, Beezhold D, Weissman D, Hogan M, Wilson N, Schmechel D: IgE reactivity to Paecilomyces variotii antigens in fungal sensitized patients. J Allergy Clin Immunol 2007;119:S187.
266.
Giannini EH, Northey WT, Leathers CR: The allergenic significance of certain fungi rarely reported as allergens. Ann Allergy 1975; 35:372–376.
267.
Martinez Ordaz VA, Rincon Castaneda CB, Lopez Campos C, Velasco Rodriguez VM: Cutaneous hypersensitivity in patients with bronchial asthma in La Comarca Lagunera (in Spanish). Rev Alerg Mex 1997;44:142–145.
268.
Mohovic J, Gambale W, Croce J: Cutaneous positivity in patients with respiratory allergies to 42 allergenic extracts of airborne fungi isolated in São Paulo, Brazil. Allergol Immunopathol (Madr) 1988;16:397–402.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
